Please use this identifier to cite or link to this item: http://buratest.brunel.ac.uk/handle/2438/11478
Title: Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement
Authors: Petrou, S
Rivero-Arias, O
Dakin, H
Longworth, L
Oppe, M
Froud, R
Gray, A
Keywords: Mapping;Outcome Measures;Preferences;Reporting
Issue Date: 2015
Publisher: Taylor & Francis
Citation: Journal of Medical Economics: 1070554, 1-7, 2015
Abstract: Reproduction in whole or part not permitted ‘Mapping’ onto generic preference-based outcome measures is increasingly being used as a means of generating health utilities for use within health economic evaluations. Despite publication of technical guides for the conduct of mapping research, guidance for the reporting of mapping studies is currently lacking. The MAPS (MApping onto Preference-based measures reporting Standards) statement is a new checklist, which aims to promote complete and transparent reporting of mapping studies. The primary audiences for the MAPS statement are researchers reporting mapping studies, the funders of the research, and peer reviewers and editors involved in assessing mapping studies for publication. A de novo list of 29 candidate reporting items and accompanying explanations was created by a working group comprised of six health economists and one Delphi methodologist. Following a two-round, modified Delphi survey with representatives from academia, consultancy, health technology assessment agencies and the biomedical journal editorial community, a final set of 23 items deemed essential for transparent reporting, and accompanying explanations, was developed. The items are contained in a user friendly 23 item checklist. They are presented numerically and categorised within six sections, namely: (i) title and abstract; (ii) introduction; (iii) methods; (iv) results; (v) discussion; and (vi) other. The MAPS statement is best applied in conjunction with the accompanying MAPS explanation and elaboration document. It is anticipated that the MAPS statement will improve the clarity, transparency and completeness of reporting of mapping studies. To facilitate dissemination and uptake, the MAPS statement is being co-published by seven health economics and quality of life journals, and broader endorsement is encouraged. The MAPS working group plans to assess the need for an update of the reporting checklist in five years’ time.
Description: This article is a joint publication by the Journal of Medical Economics, Pharmacoeconomics, Medical Decision Making, Applied Health Economics, Quality of Life Research, Health and Quality of Life Outcomes, and the International Journal of Technology Assessment in Health Care. Each publisher holds a shared copyright or creative common license agreement.
URI: http://www.tandfonline.com/doi/full/10.3111/13696998.2015.1070554
http://bura.brunel.ac.uk/handle/2438/11478
DOI: http://dx.doi.org/10.3111/13696998.2015.1070554
ISSN: 1369-6998
1941-837X
Appears in Collections:Health Economics Research Group (HERG)

Files in This Item:
File Description SizeFormat 
MAPS JME.pdf421.94 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.